Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

• Үндсэн зохиолчид: Mehdi Sowlati (Зохиогч), Silviu-Horia Morariu (Зохиогч), Olguta Orzan (Зохиогч), Stefano Veraldi (Зохиогч), Roni P. Dodiuk-Gad (Зохиогч), Remus I. Orasan (Зохиогч), Cristian Gainaru (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Introduction Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydro...